Top Markets
Coin of the day
Medios AG Medios AG

Medios AG

ILM1
Pozycja w akcjach #15684
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Cena akcji
$13.21
Kapitalizacja rynkowa
$337.03M
Zmiana (1 dzień)
-0.36%
Zmiana (1 rok)
-28.32%
Kraj
DE
Handel Medios AG (ILM1)

Kategoria

Historia stopy dywidendy dla Medios AG (ILM1)
Stopa dywidendy (TTM) dla Medios AG (symbol akcji: ILM1) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Medios AG (ILM1) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji